[1] Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease[J]. Nat Rev Neurosci, 2013, 14(6):383-400.[2] Baskys A, Bayazitov I, Fang L, et al. Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis[J]. Neuropharmacology,2005, 49 Suppl 1:146-156.[3] Yu S, Uéda K, Chan P. Alpha-synuclein and dopamine metabolism[J]. Mol Neurobiol,2005,31(1-3):243-254. Review.[4] Cheng F, Li X, Li Y, et al. Alpha-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death[J]. Neurochem,2011, 119(4):815-825.[5] Wu H Y, Yuen E Y, Lu Y F, et al. Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons[J]. J Biol Chem,2005, 280(22):21588-21593.[6] 李昕,杨巍巍,李雁,等. 一种检测帕金森患者血浆促进α-突触核蛋白寡聚体形成能力的方法[J]. 首都医科大学学报,2013,34(6):830-834.[7] Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels [J]. Pharmacol Rev, 1999, 51(1):7-61. Reviews.[8] Kiss J P, Szasz B K, Fodor L, et al. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine[J]. Neurochem Int,2012, 60(2):170-176.[9] Cheng F, Vivacqua G, Yu S. The role of α-synuclein in neurotransmission and synaptic plasticity [J]. J Chem Neuroanat,2011, 42(4):242-248. |